ID
22328
Beschreibung
A Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Rosiglitazone (Extended Release Tablets) on Cerebral Glucose Utilization and Cognition in Subjects With Mild to Moderate Alzheimer's Disease (AD) Medicine: rosiglitazone, Condition: Alzheimer's Disease, Phase: 2, Clinical Study ID: 49653/461, This form is to be performed in/after Screening Period 1, Weeks 2, 1 Month +/- 3 Days, 2 Months, 4 Months, 6 Months +/- 1 week, 8 Months, 10 Months, 12 Months +/- 1 week and Follow Up. Sponsor: GSK Source & Descriptions: https://clinicaltrials.gov/ct2/show/NCT00265148?term=NCT00265148&rank=1
Link
https://clinicaltrials.gov/ct2/show/NCT00265148?term=NCT00265148&rank=1
Stichworte
Versionen (2)
- 30.05.17 30.05.17 -
- 30.05.17 30.05.17 -
Hochgeladen am
30. Mai 2017
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 3.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Dosing and Compliance Effects of Rosiglitazone on Cerebral Glucose Utilization and Cognition in Subjects With Alzheimer's Disease NCT00265148
Dosing and Compliance Effects of Rosiglitazone on Cerebral Glucose Utilization and Cognition in Subjects With Alzheimer's Disease NCT00265148
Beschreibung
Investigational Product Compliance
Alias
- UMLS CUI-1
- C0304229
- UMLS CUI-2
- C1321605
Beschreibung
Investigational Product
Datentyp
text
Alias
- UMLS CUI [1]
- C0304229
Beschreibung
Start date
Datentyp
date
Maßeinheiten
- dd/mm/yy
Alias
- UMLS CUI [1,1]
- C0808070
- UMLS CUI [1,2]
- C0304229
Beschreibung
Stop Date
Datentyp
date
Maßeinheiten
- dd/mm/yy
Alias
- UMLS CUI [1,1]
- C0806020
- UMLS CUI [1,2]
- C0304229
Beschreibung
IP Container No.
Datentyp
float
Alias
- UMLS CUI [1,1]
- C0180098
- UMLS CUI [1,2]
- C0304229
Beschreibung
Total number of Tablets Dispensed
Datentyp
float
Alias
- UMLS CUI [1,1]
- C0805077
- UMLS CUI [1,2]
- C0039225
Beschreibung
Total number of Tablets Returned
Datentyp
float
Alias
- UMLS CUI [1,1]
- C2699071
- UMLS CUI [1,2]
- C0039225
Beschreibung
Discontinuation
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0457454
- UMLS CUI [1,2]
- C0304229
Ähnliche Modelle
Dosing and Compliance Effects of Rosiglitazone on Cerebral Glucose Utilization and Cognition in Subjects With Alzheimer's Disease NCT00265148
C0011008 (UMLS CUI [1,2])
C0013227 (UMLS CUI [2,1])
C0040223 (UMLS CUI [2,2])
C0237753 (UMLS CUI [1,2])
C1321605 (UMLS CUI-2)
C0304229 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,2])
C0039225 (UMLS CUI [1,2])
C0039225 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,2])